POFUT2
Basic information
Region (hg38): 21:45263928-45287898
Previous symbols: [ "C21orf80" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the POFUT2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 27 | 30 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 1 | |||||
Total | 0 | 0 | 28 | 2 | 2 |
Variants in POFUT2
This is a list of pathogenic ClinVar variants found in the POFUT2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
21-45265486-T-C | not specified | Uncertain significance (Oct 29, 2024) | ||
21-45265520-C-T | not specified | Uncertain significance (Dec 05, 2022) | ||
21-45265555-G-A | not specified | Uncertain significance (May 25, 2022) | ||
21-45265635-C-T | Benign (Jun 26, 2018) | |||
21-45267633-C-G | not specified | Uncertain significance (Apr 12, 2022) | ||
21-45267662-G-A | not specified | Uncertain significance (Dec 07, 2024) | ||
21-45267680-A-G | not specified | Uncertain significance (May 30, 2023) | ||
21-45267684-C-T | not specified | Uncertain significance (Dec 21, 2022) | ||
21-45269881-G-A | Benign (Jul 31, 2018) | |||
21-45269901-C-T | not specified | Uncertain significance (Oct 25, 2023) | ||
21-45269937-T-A | not specified | Uncertain significance (Dec 11, 2024) | ||
21-45270002-C-T | Likely benign (Nov 01, 2022) | |||
21-45270005-G-A | not specified | Likely benign (Feb 12, 2025) | ||
21-45277109-G-A | not specified | Uncertain significance (Dec 05, 2024) | ||
21-45277127-C-T | not specified | Uncertain significance (Mar 30, 2024) | ||
21-45277136-G-A | not specified | Uncertain significance (Jul 26, 2022) | ||
21-45277138-C-T | not specified | Uncertain significance (Aug 11, 2022) | ||
21-45278119-C-T | not specified | Uncertain significance (Oct 26, 2022) | ||
21-45282352-G-C | not specified | Uncertain significance (Sep 26, 2023) | ||
21-45282383-C-T | not specified | Uncertain significance (May 17, 2023) | ||
21-45282398-C-T | not specified | Uncertain significance (Jun 11, 2021) | ||
21-45282419-C-T | not specified | Uncertain significance (Jul 21, 2021) | ||
21-45282435-C-G | not specified | Uncertain significance (Jul 16, 2024) | ||
21-45282445-C-T | not specified | Uncertain significance (Nov 19, 2024) | ||
21-45283438-C-T | not specified | Uncertain significance (Jan 21, 2025) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
POFUT2 | protein_coding | protein_coding | ENST00000349485 | 9 | 23971 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000216 | 0.996 | 125729 | 0 | 19 | 125748 | 0.0000756 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.16 | 204 | 256 | 0.796 | 0.0000160 | 2775 |
Missense in Polyphen | 67 | 99.591 | 0.67275 | 1083 | ||
Synonymous | -1.65 | 134 | 112 | 1.20 | 0.00000816 | 827 |
Loss of Function | 2.52 | 10 | 23.1 | 0.433 | 0.00000107 | 256 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000116 | 0.000116 |
Ashkenazi Jewish | 0.000106 | 0.0000992 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000925 | 0.0000924 |
European (Non-Finnish) | 0.0000622 | 0.0000615 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.000138 | 0.000131 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the reaction that attaches fucose through an O-glycosidic linkage to a conserved serine or threonine residue in the consensus sequence C1-X(2,3)-S/T-C2-X(2)-G of thrombospondin type 1 repeats where C1 and C2 are the first and second cysteines, respectively. O-fucosylates members of several protein families including the ADAMTS family, the thrombosporin (TSP) and spondin families. The O-fucosylation of TSRs is also required for restricting epithelial to mesenchymal transition (EMT), maintaining the correct patterning of mesoderm and localization of the definite endoderm (By similarity). Required for the proper secretion of ADAMTS family members such as ADAMSL1 and ADAMST13. {ECO:0000250, ECO:0000269|PubMed:11067851, ECO:0000269|PubMed:16464858, ECO:0000269|PubMed:17395588, ECO:0000269|PubMed:17395589, ECO:0000269|PubMed:22588082}.;
- Pathway
- Other types of O-glycan biosynthesis - Homo sapiens (human);Post-translational protein modification;Metabolism of proteins;O-glycosylation of TSR domain-containing proteins;O-linked glycosylation
(Consensus)
Recessive Scores
- pRec
- 0.151
Intolerance Scores
- loftool
- 0.275
- rvis_EVS
- -0.11
- rvis_percentile_EVS
- 45.49
Haploinsufficiency Scores
- pHI
- 0.158
- hipred
- N
- hipred_score
- 0.488
- ghis
- 0.584
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.696
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pofut2
- Phenotype
- homeostasis/metabolism phenotype; cellular phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype;
Zebrafish Information Network
- Gene name
- pofut2
- Affected structure
- cranial nerve X
- Phenotype tag
- abnormal
- Phenotype quality
- position
Gene ontology
- Biological process
- mesoderm formation;fucose metabolic process;regulation of gene expression;regulation of epithelial to mesenchymal transition;protein O-linked fucosylation;regulation of secretion
- Cellular component
- endoplasmic reticulum membrane;Golgi apparatus
- Molecular function
- peptide-O-fucosyltransferase activity